Explained herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-sensitive medicine, these devices such as a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxygen and comprises e